Claude Maraoui - Jul 21, 2022 Form 4 Insider Report for Journey Medical Corp (DERM)

Role
President & CEO, Director
Signature
/s/ Ramsey Alloush, attorney-in-fact
Stock symbol
DERM
Transactions as of
Jul 21, 2022
Transactions value $
$0
Form type
4
Date filed
7/25/2022, 09:34 AM
Previous filing
Apr 4, 2022
Next filing
May 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DERM Common Stock, par value $0.0001 per share Award $0 +300K +15.85% $0.00 2.19M Jul 21, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 21, 2022, the reporting person was granted 300,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan. One-fourth of the shares will vest on each of July 21, 2023, 2024, 2025 and 2026, subject to the reporting person's continuous service with the Issuer.
F2 Includes 742,530 restricted stock units, 300,000 of which will vest over various time periods as set forth in footnote 1, and 442,530 of which will vest in accordance with the following schedule: 147,362 shares on the fifteenth day of the eighteenth month following the closing of the Issuer's initial public offering (the "Tranche 1 Vesting Date"); 147,362 of which will vest nine months after the Tranche 1 Vesting Date (the "Tranche 2 Vesting Date"), and 147,806 of which will vest nine months after the Tranche 2 Vesting Date.

Remarks:

Exhibit 24 - Power of Attorney